These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 5741236)
21. Cosmetic and dermatology: bleaching creams. Engasser PG; Maibach HI J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611 [TBL] [Abstract][Full Text] [Related]
22. Nail staining due to hydroquinone skin-lightening creams. Mann RJ; Harman RR Br J Dermatol; 1983 Mar; 108(3):363-5. PubMed ID: 6219692 [No Abstract] [Full Text] [Related]
23. Use of hydroquinone as a bleaching cream. Yi K; Hart LL Ann Pharmacother; 1993 May; 27(5):592-3. PubMed ID: 8347912 [No Abstract] [Full Text] [Related]
24. Topical use of hydroquinone as a depigmenting agent. Arndt KA; Fitzpatrick TB JAMA; 1965 Nov; 194(9):965-7. PubMed ID: 5897965 [No Abstract] [Full Text] [Related]
25. Dermatitic and pigmentary reactions to monobenzyl ether of hydroquinone: report of two cases. DORSEY CS Arch Dermatol; 1960 Feb; 81():245-8. PubMed ID: 13817717 [No Abstract] [Full Text] [Related]
26. [Treatment of hyperpigmentations by hydroquinone derivatives]. SIDI E; BOURGEOIS-SPINASSE J; PLANAT P Presse Med (1893); 1961 Dec; 69():2369-72. PubMed ID: 13912544 [No Abstract] [Full Text] [Related]
27. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma. Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872 [TBL] [Abstract][Full Text] [Related]
28. [Melanoleukoderma following treatment with hydroquinone monobenzylether]. Balabanow K; Durmischev AL; Tschernozemsky I Asthet Med (Berl); 1968 Oct; 17(10):233-4. PubMed ID: 5306153 [No Abstract] [Full Text] [Related]
29. Hydroquinone--a harmful agent. Fernandes D S Afr Med J; 2000 Sep; 90(9):829. PubMed ID: 11081118 [No Abstract] [Full Text] [Related]
30. [Leucodermia acquisita areata caused by monobenzylether of hydroquinone (author's transl)]. Hegyi E; Valková P; Mat'oska J Cesk Dermatol; 1979 Feb; 54(1):6-8. PubMed ID: 761240 [No Abstract] [Full Text] [Related]
31. [Molecular basis of pigmentation disorders in skin diseases]. Drukała J; Bobis S; Zabińska-Płazak E; Wojas-Pelc A Przegl Lek; 2009; 66(3):145-9. PubMed ID: 19689040 [TBL] [Abstract][Full Text] [Related]
32. [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients]. Haas N Med Klin (Munich); 1988 May; 83(11):385-6, 390. PubMed ID: 3405155 [No Abstract] [Full Text] [Related]
33. Efficacy and safety of cryotherapy vs. trichloroacetic acid in the treatment of solar lentigo. Raziee M; Balighi K; Shabanzadeh-Dehkordi H; Robati RM J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):316-9. PubMed ID: 18021205 [TBL] [Abstract][Full Text] [Related]
34. [25 cases of dyschromia caused by hydroquinone]. GARZA TOBA M Rev Asoc Medica Mex; 1961 Aug; 41():353-9. PubMed ID: 13703807 [No Abstract] [Full Text] [Related]
35. [THE TREATMENT OF HYPERPIGMENTATIONS OF THE SKIN WITH DEPIGMAN]. BEROWA N Z Haut Geschlechtskr; 1964 May; 36():317-9. PubMed ID: 14218143 [No Abstract] [Full Text] [Related]